Flex Pharma To Report First Quarter 2015 Results On May 6, 2015

BOSTON--(BUSINESS WIRE)--Click to Tweet Flex Pharma, Inc. (NASDAQ: FLKS), a biotechnology company that is developing innovative and proprietary treatments for exercise-associated muscle cramps, nocturnal leg cramps and spasms associated with severe neuromuscular conditions, today announced that it will report its financial results for the quarter ended March 31, 2015 on Wednesday, May 6, 2015 before the U.S. financial markets open.

Help employers find you! Check out all the jobs and post your resume.